Top Back to top

The outcome of second and third allogeneic conditioned HSCT in patients with non-SCID primary immune deficiency (PID) following primary or secondary graft failure

Inborn Errors Working Party (IEWP)
Study number:
Short title:
Outcome of second allo in non-SCID PID patients
Primary objective:
Key inclusion criteria:
Principal investigator:
Zohreh Nademi
EBMT Study coordinator:
Tiar Sirait
Study coordinator email: